Covid 19 Vaccine Candidate
- All
- News
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
Instagram Blocks Robert F. Kennedy Jr Over COVID-19 Vaccine Misinformation
- Friday February 12, 2021
- Associated Press
Instagram banned Robert F. Kennedy Jr., son of former presidential candidate Robert F. Kennedy, from repeatedly posting misinformation about vaccine safety and COVID-19.
- www.gadgets360.com
-
Germany Approves First Trial of COVID-19 Vaccine Candidate
- Wednesday April 22, 2020
- Agence France-Presse
Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country's regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.
- www.gadgets360.com
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
Instagram Blocks Robert F. Kennedy Jr Over COVID-19 Vaccine Misinformation
- Friday February 12, 2021
- Associated Press
Instagram banned Robert F. Kennedy Jr., son of former presidential candidate Robert F. Kennedy, from repeatedly posting misinformation about vaccine safety and COVID-19.
- www.gadgets360.com
-
Germany Approves First Trial of COVID-19 Vaccine Candidate
- Wednesday April 22, 2020
- Agence France-Presse
Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country's regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.
- www.gadgets360.com